252 related articles for article (PubMed ID: 37385075)
41. Therapeutic advantage of pro-electrophilic drugs to activate the Nrf2/ARE pathway in Alzheimer's disease models.
Lipton SA; Rezaie T; Nutter A; Lopez KM; Parker J; Kosaka K; Satoh T; McKercher SR; Masliah E; Nakanishi N
Cell Death Dis; 2016 Dec; 7(12):e2499. PubMed ID: 27906174
[TBL] [Abstract][Full Text] [Related]
42. CD36 upregulation mediated by intranasal LV-NRF2 treatment mitigates hypoxia-induced progression of Alzheimer's-like pathogenesis.
Wang CY; Wang ZY; Xie JW; Cai JH; Wang T; Xu Y; Wang X; An L
Antioxid Redox Signal; 2014 Dec; 21(16):2208-30. PubMed ID: 24702189
[TBL] [Abstract][Full Text] [Related]
43. Oral administration of methysticin improves cognitive deficits in a mouse model of Alzheimer's disease.
Fragoulis A; Siegl S; Fendt M; Jansen S; Soppa U; Brandenburg LO; Pufe T; Weis J; Wruck CJ
Redox Biol; 2017 Aug; 12():843-853. PubMed ID: 28448946
[TBL] [Abstract][Full Text] [Related]
44. Chronic vitamin D
Lin J; Niu Z; Xue Y; Gao J; Zhang M; Li M; Peng Y; Zhang S; Li W; Zhang Q; Li X
Neurosci Lett; 2022 Jul; 783():136725. PubMed ID: 35697158
[TBL] [Abstract][Full Text] [Related]
45. Treadmill exercise promotes E3 ubiquitin ligase to remove amyloid β and P-tau and improve cognitive ability in APP/PS1 transgenic mice.
Xu L; Li M; Wei A; Yang M; Li C; Liu R; Zheng Y; Chen Y; Wang Z; Wang K; Wang T
J Neuroinflammation; 2022 Oct; 19(1):243. PubMed ID: 36195875
[TBL] [Abstract][Full Text] [Related]
46. Novel target for treating Alzheimer's Diseases: Crosstalk between the Nrf2 pathway and autophagy.
Zhang W; Feng C; Jiang H
Ageing Res Rev; 2021 Jan; 65():101207. PubMed ID: 33144123
[TBL] [Abstract][Full Text] [Related]
47. Krüppel-like factor 5 accelerates the pathogenesis of Alzheimer's disease via BACE1-mediated APP processing.
Wang Y; Cui Y; Liu J; Song Q; Cao M; Hou Y; Zhang X; Wang P
Alzheimers Res Ther; 2022 Jul; 14(1):103. PubMed ID: 35883144
[TBL] [Abstract][Full Text] [Related]
48. Lack of BACE1 S-palmitoylation reduces amyloid burden and mitigates memory deficits in transgenic mouse models of Alzheimer's disease.
Andrew RJ; Fernandez CG; Stanley M; Jiang H; Nguyen P; Rice RC; Buggia-Prévot V; De Rossi P; Vetrivel KS; Lamb R; Argemi A; Allaert ES; Rathbun EM; Krause SV; Wagner SL; Parent AT; Holtzman DM; Thinakaran G
Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9665-E9674. PubMed ID: 29078331
[TBL] [Abstract][Full Text] [Related]
49. The potential role of Keap1-Nrf2 pathway in the pathogenesis of Alzheimer's disease, type 2 diabetes, and type 2 diabetes-related Alzheimer's disease.
He L; Sun Y
Metab Brain Dis; 2021 Oct; 36(7):1469-1479. PubMed ID: 34129198
[TBL] [Abstract][Full Text] [Related]
50. Farrerol attenuates β-amyloid-induced oxidative stress and inflammation through Nrf2/Keap1 pathway in a microglia cell line.
Cui B; Zhang S; Wang Y; Guo Y
Biomed Pharmacother; 2019 Jan; 109():112-119. PubMed ID: 30396067
[TBL] [Abstract][Full Text] [Related]
51. Stress level of glucocorticoid exacerbates neuronal damage and Aβ production through activating NLRP1 inflammasome in primary cultured hippocampal neurons of APP-PS1 mice.
Yang L; Zhou H; Huang L; Su Y; Kong L; Ji P; Sun R; Wang C; Li W; Li W
Int Immunopharmacol; 2022 Sep; 110():108972. PubMed ID: 35777263
[TBL] [Abstract][Full Text] [Related]
52. Natural Dietary Supplementation of Anthocyanins via PI3K/Akt/Nrf2/HO-1 Pathways Mitigate Oxidative Stress, Neurodegeneration, and Memory Impairment in a Mouse Model of Alzheimer's Disease.
Ali T; Kim T; Rehman SU; Khan MS; Amin FU; Khan M; Ikram M; Kim MO
Mol Neurobiol; 2018 Jul; 55(7):6076-6093. PubMed ID: 29170981
[TBL] [Abstract][Full Text] [Related]
53. Hydrogen sulfide down-regulates BACE1 and PS1 via activating PI3K/Akt pathway in the brain of APP/PS1 transgenic mouse.
He XL; Yan N; Chen XS; Qi YW; Yan Y; Cai Z
Pharmacol Rep; 2016 Oct; 68(5):975-82. PubMed ID: 27372924
[TBL] [Abstract][Full Text] [Related]
54. microRNA-592 blockade inhibits oxidative stress injury in Alzheimer's disease astrocytes via the KIAA0319-mediated Keap1/Nrf2/ARE signaling pathway.
Wu GD; Li ZH; Li X; Zheng T; Zhang DK
Exp Neurol; 2020 Feb; 324():113128. PubMed ID: 31759899
[TBL] [Abstract][Full Text] [Related]
55. Berberine ameliorates iron levels and ferroptosis in the brain of 3 × Tg-AD mice.
Li X; Chen J; Feng W; Wang C; Chen M; Li Y; Chen J; Liu X; Liu Q; Tian J
Phytomedicine; 2023 Sep; 118():154962. PubMed ID: 37506403
[TBL] [Abstract][Full Text] [Related]
56. Pseudoginsenoside-F11 alleviates cognitive deficits and Alzheimer's disease-type pathologies in SAMP8 mice.
Zhang Z; Yang J; Liu C; Xie J; Qiu S; Yang X; Wu C
Pharmacol Res; 2019 Jan; 139():512-523. PubMed ID: 30394318
[TBL] [Abstract][Full Text] [Related]
57. Reduction of beta-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease.
Paris D; Ganey NJ; Laporte V; Patel NS; Beaulieu-Abdelahad D; Bachmeier C; March A; Ait-Ghezala G; Mullan MJ
J Neuroinflammation; 2010 Mar; 7():17. PubMed ID: 20211007
[TBL] [Abstract][Full Text] [Related]
58. The cysteine protease inhibitor, E64d, reduces brain amyloid-β and improves memory deficits in Alzheimer's disease animal models by inhibiting cathepsin B, but not BACE1, β-secretase activity.
Hook G; Hook V; Kindy M
J Alzheimers Dis; 2011; 26(2):387-408. PubMed ID: 21613740
[TBL] [Abstract][Full Text] [Related]
59. Andrographolide emeliorates maltol aluminium-induced neurotoxicity via regulating p62-mediated Keap1-Nrf2 pathways in PC12 cells.
Lu J; Gu L; Li Q; Wu N; Li H; Zhang X
Pharm Biol; 2021 Dec; 59(1):232-241. PubMed ID: 33632062
[TBL] [Abstract][Full Text] [Related]
60. Elevation of brain magnesium prevents synaptic loss and reverses cognitive deficits in Alzheimer's disease mouse model.
Li W; Yu J; Liu Y; Huang X; Abumaria N; Zhu Y; Huang X; Xiong W; Ren C; Liu XG; Chui D; Liu G
Mol Brain; 2014 Sep; 7():65. PubMed ID: 25213836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
